Venous thrombosis prophylaxis in oncology: Knowledge, practice, and attitude study among oncologists in Armenia.

N Nune Karapetyan (Yerevan State Medical University, Immune Oncology Research Institute, Yeolyan Hematology and Oncology Center, Yerevan, Armenia) L Liana Safaryan (Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia) D Davit Zohrabyan (Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia) Z Zaruhi Arzumanyan (American University of Armenia, School of Public Health, Yerevan, Armenia) S Samvel Bardakhchyan (1Yeolyan Hematology and Oncology Center, Yerevan, Armenia) A Amalya Sargsyan M Mariam Mailyan (Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia) M Mariam Khachatryan (Yerevan State Medical University after M. Heratsi, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute, Yerevan, Armenia) S Sona Karamyan (Yerevan State Medical University after M. Heratsi, Yerevan, Armenia) M Meri Ghayamyan (Yerevan State Medical University after M. Heratsi, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute, Yerevan, Armenia) B Benik Mkhitaryan (Immune Oncology Research Institute, Yerevan, Armenia) S Sahak Azizyan (Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia) H Hayk Avagyan (Yeolyan Hematology and Oncology Center, Yerevan, Armenia) H Hovsep Gharadaghyan (Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia) A Armen Arzumanyan (Yerevan State Medical University, Yeolyan Hematology and Oncology Center, Yerevan, Armenia) A Armen Avagyan (Yerevan State Medical University, Mikaelyan Institute of Surgery, Yerevan, Armenia) L Lilit Harutyunyan (Yerevan State Medical University, Mikaelyan Institute of Surgery, Yerevan, Armenia) H Heghine Khachatryan (Hemophilia and Thrombosis Center, Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia)

Abstract

e21027 Background: Increased risk of venous thromboembolism (VTE) is observed among patients with malignancies, characterized by an incidence of 5.8 per 100 person-years. The role of VTE prophylaxis is crucial as cancer-associated thrombosis (CAT) is the 2nd leading cause of mortality among patients with solid tumors. The current study assesses oncologists' knowledge, attitude, and practice (KAP) on CAT prophylaxis in Armenia. Methods: The study utilizes a cross-sectional design. Medical Oncologists (MO), Radiation Oncologists (RO), and Surgical Oncologists (SO) were approached from the three biggest cancer centers in the capital of Armenia. Convenient sampling was performed and the study tool was distributed through paper-based and electronic self-administered questionnaires. The latter was adopted from the study by Shangpeng Feng et al., 2021. To analyze the data, KAP scores were calculated. Chi-square analysis was done to check for the association between KAP and predictors. For that purpose, KAP scores were categorized into binomial variables (high/low knowledge, favorable/unfavorable practice, and positive/negative attitude). Data was analyzed through SPSS. Results: In total, 45 subjects were interviewed. M:F ratio was 1.14:1. Median age: 32 years (26:72). Overall, 40.0%, 11.1%, and 48.9% of MO, RO, and SO respectively were enrolled. Of those, 66.7% completed their training. Median work experience was 5 years (1:48). On average, the knowledge score was 15.0 (range: 7-25; SD - 5.0). The high level of knowledge was noted in 48.9% of cases. Knowledge was significantly associated with the subspecialty (p - .000) with higher scores among SOs. The mean attitude score was 6.9 (range: 1-10; SD - 1.75). The subjects demonstrated predominantly negative attitudes (66.7%) towards CAT prophylaxis. On average, the practice score was 3.0 (range: 0-5; SD - 1.4). Favorable practice was noted in 42.2% of cases. Training completion was significantly associated with Oncologists’ practice (p - .033) exhibiting poorer scores among those who did not complete their residency training. A moderate positive correlation was observed between Oncologists' attitudes and practice (r - .4, p - .007). Conclusions: The evaluation showed intermediate scores that suggest room for improvement. Hence, national interventions are required to ensure adequate adherence to CAT prophylaxis.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (18)

N

Nune Karapetyan

Yerevan State Medical University, Immune Oncology Research Institute, Yeolyan Hematology and Oncology Center, Yerevan, Armenia

L

Liana Safaryan

Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia

D

Davit Zohrabyan

Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia

Z

Zaruhi Arzumanyan

American University of Armenia, School of Public Health, Yerevan, Armenia

S

Samvel Bardakhchyan

1Yeolyan Hematology and Oncology Center, Yerevan, Armenia

A

Amalya Sargsyan

M

Mariam Mailyan

Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia

M

Mariam Khachatryan

Yerevan State Medical University after M. Heratsi, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute, Yerevan, Armenia

S

Sona Karamyan

Yerevan State Medical University after M. Heratsi, Yerevan, Armenia

M

Meri Ghayamyan

Yerevan State Medical University after M. Heratsi, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute, Yerevan, Armenia

B

Benik Mkhitaryan

Immune Oncology Research Institute, Yerevan, Armenia

S

Sahak Azizyan

Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia

H

Hayk Avagyan

Yeolyan Hematology and Oncology Center, Yerevan, Armenia

H

Hovsep Gharadaghyan

Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia

A

Armen Arzumanyan

Yerevan State Medical University, Yeolyan Hematology and Oncology Center, Yerevan, Armenia

A

Armen Avagyan

Yerevan State Medical University, Mikaelyan Institute of Surgery, Yerevan, Armenia

L

Lilit Harutyunyan

Yerevan State Medical University, Mikaelyan Institute of Surgery, Yerevan, Armenia

H

Heghine Khachatryan

Hemophilia and Thrombosis Center, Yeolyan Hematology and Oncology Center, MoH, RA, Yerevan, Armenia